Schedule 13G ownership disclosure

Axsome Therapeutics Inc

Security class unavailable · CUSIP: 05464T104

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,333,975
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-021703
Form type
SC 13G/A
Filer
Axsome Therapeutics, Inc.
CIK
CIK 1579428
Filed
Feb 14, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub